Resolved

AWIQLI

NOVO NORDISK CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of AWIQLI in Canada?

Not currently. The most recent shortage report for AWIQLI 2100UNIT is marked resolved (last updated October 27, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength2100UNIT

Report last updated2026-10-27

Checked by MedShort2026-11-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02546221

Strength

2100UNIT

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

INSULIN ICODEC

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Delay in shipping of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from NOVO NORDISK CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVELLE

DIN 02249405

ACTIVELLE LD

DIN 02309009

AWIQLI

700UNIT · DIN 02546205

AWIQLI

1050UNIT · DIN 02546213

ESPEROCT

1000UNIT · DIN 02490072

ESPEROCT

3000UNIT · DIN 02490102